Modulation of blood cell activation by four commonly used anticoagulants.
Engstad CS, Gutteberg TJ, Osterud B
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of anticoagulant on monocyte, platelet, and neutrophil activation in whole blood. LPS induction of TF activity, release of TNFalpha, release of lactoferrin, and secretion of PF4 were measured. PBMC were isolated and frozen at -20 degrees C prior to quantification of TF activity. Platelet poor plasma was frozen at -70 degrees C prior to analysis.
Summary of Findings
Regardless of anticoagulant, TF activity increased as incubation time with LPS increased from 1 to 2 hours, peaking at 2 hours. TF activity decreased again after incubation with LPS of heparinized whole blood for 4 h or EDTA blood for 5 h. PBMC TF activity was significantly lower when EDTA or citrate was used as an anticoagulant rather than heparin, or hirudin. Regardless of anticoagulant, only LPS concentrations of 0.5 ng/mL significantly increased TF activity, and higher concentrations did not result in further increases in activity. As with TF activity, TNFalpha levels were affected by increasing incubation time with LPS. TNFalpha concentrations were significantly lower in platelet poor plasma from whole blood anticoagulated with EDTA when compared to citrate, heparin, or hirudin. TNFalpha concentrations increased when LPS concentrations were increased from 0.1 ng/mL to 5 ng/mL, but no further increases were seen with LPS concentrations of 10, 50, or 100 ng/mL, regardless of anticoagulant. Lactoferrin release was greatest in platelet poor plasma from hirudinized blood, followed by heparinized blood, then citrated blood, and least in EDTA blood. Platelet poor plasma from heparinized blood had significantly higher levels of PF4 than plasma from EDTA, citrated, Fragmin, or hirudinized blood. While incubation time at 37 degrees C had no effect on PF4 in EDTA or citrated blood, increasing incubation time increased plasma PF4 concentrations in heparinized, hirudinized, and Fragmin blood. LPS concentration had no significant effects on plasma PF4 concentration for any anticoagulant.
Biospecimens
FluidBloodFluidPlasmaCellBloodPreservation Types
FrozenDiagnoses
NormalPlatforms
ProteinEnzyme assayProteinELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant CitrateEDTAFragminHeparinHirudinBiospecimen Aliquots and Components Blood and blood products Peripheral blood mononuclear cellsPlatelet-poor plasmaAnalyte Extraction and Purification Analyte isolation method 0.05 ng/mL LPS0.1 ng/mL LPS0.5 ng/mL LPS1.5 ng/mL LPS10 ng/mL LPS100 ng/mL LPS50 ng/mL LPSSaline incubationAnalyte Extraction and Purification Incubation duration/condition 0 min at 37 degrees C1 h with LPS10 min at 37 degrees C15 min at 37 degrees C2 h with LPS3 h with LPS30 min at 37 degrees C4 h with LPS5 h with LPS5 min at 37 degrees C6 h with LPS60 min at 37 degrees C90 min at 37 degrees C